Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritaka Suga

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Respiratory Research|July 16, 2011
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trialHiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, et al.
Respiratory Investigation|November 2, 2015
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in JapanYoshio Taguchi, Masahito Ebina, Seishu Hashimoto, et al.
Respirology (Carlton, Vic.)|March 22, 2006
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosisAkihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, et al.
BMC Pulmonary Medicine|June 8, 2023
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, et al.
Radiology|October 2, 2002
Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patientsTakeshi Johkoh, Nestor L Müller, Thomas V Colby, et al.
Respiratory Research|December 1, 2020
Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in JapanKimiyuki Ikeda, Hirofumi Chiba, Hirotaka Nishikiori, et al.
Cancer Science|April 24, 2003
Expression of constitutively activated EGFRvIII in non-small cell lung cancerIsamu Okamoto, Lawrence C Kenyon, David R Emlet, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2008
Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control studyShoji Kudoh, Harubumi Kato, Yutaka Nishiwaki, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2007
Computed tomography findings in pathological usual interstitial pneumonia: relationship to survivalHiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, et al.
Journal of Clinical Microbiology|January 5, 2002
Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosisYoshinobu Eishi, Moritaka Suga, Ikuo Ishige, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Respiratory Research|July 16, 2011
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trialHiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, et al.
Respiratory Investigation|November 2, 2015
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in JapanYoshio Taguchi, Masahito Ebina, Seishu Hashimoto, et al.
Respirology (Carlton, Vic.)|March 22, 2006
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosisAkihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, et al.
BMC Pulmonary Medicine|June 8, 2023
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, et al.
Radiology|October 2, 2002
Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patientsTakeshi Johkoh, Nestor L Müller, Thomas V Colby, et al.
Respiratory Research|December 1, 2020
Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in JapanKimiyuki Ikeda, Hirofumi Chiba, Hirotaka Nishikiori, et al.
Cancer Science|April 24, 2003
Expression of constitutively activated EGFRvIII in non-small cell lung cancerIsamu Okamoto, Lawrence C Kenyon, David R Emlet, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2008
Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control studyShoji Kudoh, Harubumi Kato, Yutaka Nishiwaki, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2007
Computed tomography findings in pathological usual interstitial pneumonia: relationship to survivalHiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, et al.
Journal of Clinical Microbiology|January 5, 2002
Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosisYoshinobu Eishi, Moritaka Suga, Ikuo Ishige, et al.
Pageof 6